By cutting in half the activity of a gene, scientists corrected many symptoms of a genetic defect in mice analogous to fragile X syndrome, a leading cause of inherited mental retardation in people.
The research suggests a new target for drug therapy for the condition, which is currently untreatable.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.